Transdermal Testosterone Attenuates Drug-Induced Lengthening of Both Early and Late Ventricular Repolarization in Older Men
dc.contributor.author | Tomaselli Muensterman, Elena | |
dc.contributor.author | Jaynes, Heather A. | |
dc.contributor.author | Sowinski, Kevin M. | |
dc.contributor.author | Overholser, Brian R. | |
dc.contributor.author | Shen, Changyu | |
dc.contributor.author | Kovacs, Richard J. | |
dc.contributor.author | Tisdale, James E. | |
dc.contributor.department | Medicine, School of Medicine | |
dc.date.accessioned | 2024-03-07T14:31:17Z | |
dc.date.available | 2024-03-07T14:31:17Z | |
dc.date.issued | 2021 | |
dc.description.abstract | We have previously reported that transdermal testosterone attenuates drug-induced QT interval lengthening in older men. However, it is unknown whether this is due to modulation of early ventricular repolarization, late repolarization, or both. In a secondary analysis of a prospective, randomized, double-blind, placebo-controlled three-way crossover study, we determined if transdermal testosterone and oral progesterone attenuate drug-induced lengthening of early and late ventricular repolarization, represented by the electrocardiographic measurements J-Tpeak c and Tpeak -Tend , respectively, as well as Tpeak -Tend /QT, a measure of transmural dispersion of repolarization. Male volunteers ≥ 65 years of age (n = 14) were randomized to receive transdermal testosterone 100 mg, oral progesterone 400 mg, or matching transdermal/oral placebo daily for 7 days. On the morning following the seventh day, subjects received intravenous ibutilide 0.003 mg/kg, after which electrocardiograms were performed serially. One subject was excluded due to difficulty in T-wave interpretation. Pre-ibutilide J-Tpeak c was lower during the testosterone phase than during progesterone and placebo (216 ± 23 vs. 227 ± 28 vs. 227 ± 21 ms, P = 0.002). Maximum post-ibutilide J-Tpeak c was also lower during the testosterone phase (233 ± 22 vs. 246 ± 29 vs. 248 ± 23 ms, P < 0.0001). Pre-ibutilide Tpeak -Tend was not significantly different during the three phases, but maximum post-ibutilide Tpeak -Tend was lower during the testosterone phase (80 ± 12 vs. 89 ± 18 vs. 86 ± 15 ms, P = 0.002). Maximum Tpeak -Tend /QT was also lower during the testosterone phase (0.199 ± 0.023 vs. 0.216 ± 0.035 vs. 0.209 ± 0.031, P = 0.005). Progesterone exerted minimal effect on drug-induced lengthening of J-Tpeak c, and no effect on Tpeak -Tend or Tpeak -Tend /QT. Transdermal testosterone attenuates drug-induced lengthening of both early and late ventricular repolarization in older men. | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | Tomaselli Muensterman E, Jaynes HA, Sowinski KM, et al. Transdermal Testosterone Attenuates Drug-Induced Lengthening of Both Early and Late Ventricular Repolarization in Older Men. Clin Pharmacol Ther. 2021;109(6):1499-1504. doi:10.1002/cpt.2072 | |
dc.identifier.uri | https://hdl.handle.net/1805/39083 | |
dc.language.iso | en_US | |
dc.publisher | Wiley | |
dc.relation.isversionof | 10.1002/cpt.2072 | |
dc.relation.journal | Clinical Pharmacology & Therapeutics | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Anti-arrhythmia agents | |
dc.subject | Electrocardiography | |
dc.subject | Progesterone | |
dc.subject | Sulfonamides | |
dc.subject | Testosterone | |
dc.title | Transdermal Testosterone Attenuates Drug-Induced Lengthening of Both Early and Late Ventricular Repolarization in Older Men | |
dc.type | Article |